Alkeran

How does it work?

Alkeran tablets and injection contain the active ingredient melphalan, which is a type of chemotherapy medicine to treat cancer called an alkylating agent.

Cancers form when some cells within the body multiply uncontrollably and abnormally. These cells spread, destroying nearby tissues. Melphalan works by stopping the cancer cells from multiplying. It does this by binding to and damaging the DNA in the cancer cells. This stops the cells from growing and multiplying.

Unfortunately, melphalan can also affect normal, healthy cells, particularly those that multiply quickly, such as blood cells and hair cells. The most important side effect is on the bone marrow where blood cells are made. Melphalan can decrease the production of blood cells, leaving people susceptible to infection. Regular blood tests are therefore needed to monitor the levels of blood cells.

In most chemotherapy regimens, doses are administered in courses at various intervals to allow normal cells to recover from the adverse effects of the anticancer medicines between doses. However, during this period, cancer cells will also recover and start to replicate again. Successful treatment depends on the administration of the next course of therapy before the cancer has regrown to its previous size, with the aimed net effect to decrease the amount of cancer with each successive course of chemotherapy.

Melphalan is used in the treatment of a range of cancers including bone marrow cancer (multiple myeloma), advanced cancer of the ovaries and advanced breast cancer. It is also used in the management of a disease called polycythaemia vera in which there are too many red cells in the blood. Melphalan can be used alone, or in combination with other anti-cancer medicines or surgery.

Melphalan can be taken by mouth as tablets, or it can be given by injection or infusion (drip) into a vein.

The injection can also be given via a procedure called regional arterial perfusion, to treat melanomas or sarcomas affecting a localised area of a limb, eg arm or leg. This is carried out under general anaesthetic. A tight band is first applied to the top of the limb to prevent the chemotherapy from reaching other areas of the body. The medicine is then injected into an artery in the arm or leg.

What is it used for?

Cancer of the plasma cells in the bone marrow (multiple myeloma)

Advanced breast cancer

Advanced cancer of the ovaries

Excessive levels of red blood cells in the blood

Childhood neuroblastoma (by injection only)

Localised skin cancer (malignant melanoma) affecting a limb (by regional arterial perfusion only - see above)

Localised soft tissue sarcoma affecting a limb (by regional arterial perfusion only - see above)

Warning!

Alkeran tablets should be swallowed whole on an empty stomach. Do not break or cut the tablets.

The tablets should be stored in a refrigerator at 2°C to 8°C and kept dry. Make sure they are kept well out of the reach of children.

Chemotherapy medicines can decrease the number of blood cells in your blood. A low white blood cell count can increase your susceptibility to infections; a low red blood cell count causes anaemia and a low platelet count can cause problems with blood clotting. For this reason, you will need regular blood tests to monitor your blood cells during treatment with this medicine. Tell your doctor immediately if you experience any of the following symptoms during your treatment, as they may indicate problems with your blood cells: unexplained bruising or bleeding, purple spots, sore mouth or throat, mouth ulcers, high temperature (fever) or other signs of infection, or suddenly feeling tired, breathless, or generally unwell.

Tell your doctor if you get a cough, or start to feel breathless or wheezy while having treatment with this medicine.

Long-term treatment with melphalan may increase the risk of developing developing leukaemia (cancer of the white blood cells) after many years. After your treatment you will have regular blood tests which will detect any possible leukaemic changes early, if they do occur. Your doctor or nurse can discuss the risks of this with you.

Your ability to become pregnant or father a child may be affected by taking this drug. It is important to discuss fertility with your doctor before starting treatment.

Use with caution in

Decreased kidney function

People who have recently had radiotherapy or other chemotherapy treatment

Not to be used in

Known sensitivity or allergy to any ingredient

This medicine should not be used if you are allergic to one or any of its ingredients. Please inform your doctor or pharmacist if you have previously experienced such an allergy. If you feel you have experienced an allergic reaction, stop using this medicine and inform your doctor or pharmacist immediately.

Pregnancy and Breastfeeding

Certain medicines should not be used during pregnancy or breastfeeding. However, other medicines may be safely used in pregnancy or breastfeeding providing the benefits to the mother outweigh the risks to the unborn baby. Always inform your doctor if you are pregnant or planning a pregnancy, before using any medicine.

This medicine should not be used during pregnancy, unless considered essential by your doctor, as it may be harmful to the unborn baby. Women who could get pregnant should use effective contraception to prevent pregnancy, and men should use effective contraception to prevent fathering a child, both during treatment, and for at least a few months after treatment is finished. Seek medical advice from your doctor.

It is not known whether this medicine passes into breast milk. Mothers who need this medicine should not breastfeed. Seek medical advice from your doctor.

Side effects

Medicines and their possible side effects can affect individual people in different ways. The following are some of the side effects that are known to be associated with this medicine. Because a side effect is stated here, it does not mean that all people using this medicine will experience that or any side effect.

Decrease in the number of white blood cells in the blood (leucopenia)

Decrease in the number of platelets in the blood (thrombocytopenia)

Nausea and vomiting

Diarrhoea

Inflammation of the lining of the mouth (stomatitis)

Skin reactions such as rash and itch

Stopping or absence of menstrual periods in women (amenorrhoea)

Hair loss (alopecia)

Excessive breakdown of red blood cells that reduces red blood cell count (haemolytic anaemia)

Changes to the lungs, such as inflammation or stiffening

Liver disorders

Sensation of warmth and/or tingling in people given high-dose Alkeran injection through a central line

The side effects listed above may not include all of the side effects reported by the drug's manufacturer. For more information about any other possible risks associated with this medicine, please read the information provided with the medicine or consult your doctor or pharmacist.

Go To Next Page>>
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care or attention by a qualified practitioner. The materials in this web site cannot and should not be used as a basis for diagnosis or choice of treatment. Conditions for use



© Copyright 1998 - 2004 NetDoctor.co.uk - All rights reserved